ABSTRACT
In the end of 2019, the epidemic of a new coronavirus (SARS-CoV-2) occurred in Wuhan and spread rapidly. Changsha, a city located south to the epicenter, was soon impacted. To control the transmission of the coronavirus and avoid nosocomial infection, triage procedures based on epidemiology were implemented in a local hospital of the city. This retrospective study analyzed the data collected during the triage period and found that COVID-19 patients were enriched seven folds into the Section A designated for rapid detection and quarantine. On the other side, roughly triple amounts of visits were received at the Section B for patients without obvious epidemiological history. Eight COVID-19 cases were spotted out of 247 suspected patients. More than 50% of the suspected patients were submitted to multiple rounds of nucleic acid analysis for SARS-CoV-2 infection. Of the 239 patients who were diagnosed as negative of the virus infection,188 were successfully revisited and none was reported as a COVID-19 case. Of the eight COVID-19 patients, three were confirmed only after multiple rounds of nucleic acid analysis. Besides comorbidities, delayed sharing of epidemiological history added another layer of complexity to the diagnosis in practice. While SARS-CoV-2 epidemic is being alerted in many countries, our report will be helpful to other colleagues in rapid identification of COVID-19 cases and controlling the transmission of the disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We thank Drs. Chengping Hu, Qiming Xiao (Department of Respiratory Medicine), Deming Tan (Department of Infectious Diseases), Xun Huang and Chunhui Li (Center for Healthcare-associated Infection Control) for their efforts in formulating the triage procedures; Drs. Yan Huang, Jun Quan and Fei Liu for facilitating data collection (Department of Infectious Diseases); Drs. Zhifei Zhan and Ge Zeng (Hunan Provincial Center for Disease Control and Prevention) for facilitating sample collection and analysis; Dr. Zhuohua Zhang (the Institute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine) for discussions and critical comments on the manuscript. The views expressed in this article are those of the authors and do not represent the official statement of Xiangya Hospital. The authors declare no competing interests. This work is supported by the National Natural Science Foundation (31700680, 31972886, 81803206), the Natural Science Foundation of Hunan Province (2018JJ2652, 2018JJ2667), the Scientific Research Project of Chinese Traditional Medicine Administration Bureau in Hunan Province (201806), the Research Projects from the Department of Science & Technology of Hunan province (2017RS3013, 2017XK2011, 2018DK2015, 2019SK1012, 2019RS1010), the Innovation-Driven Team Project from Central South University (2020CX016), China Postdoctoral Science Foundation (2018M632995), Xiangya Hospital Central South University Postdoctoral Foundation (to W. Zeng). None of the funders had any role in the study design, the collection/analysis/interpretation of data, the writing of the article and the decision to submit it for publication. The researchers confirm their independence from funders and sponsors.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author on reasonable request. Participant data without names and identifiers will be made available after approval from the corresponding author and National Health Commission.
